Astellas Pharma EBITDA Margin 2012-2024 | ALPMY

Astellas Pharma ebitda margin for the quarter ending June 30, 2024 was 18.7%.

  • Astellas Pharma average ebitda margin for 2023 was 19.74%, a 11.12% decline from 2022.
  • Astellas Pharma average ebitda margin for 2022 was 22.21%, a 6.21% decline from 2021.
  • Astellas Pharma average ebitda margin for 2021 was 23.68%, a 2.03% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Astellas Pharma EBITDA Margin 2012-2024 | ALPMY

  • Astellas Pharma average ebitda margin for 2023 was 19.74%, a 11.12% decline from 2022.
  • Astellas Pharma average ebitda margin for 2022 was 22.21%, a 6.21% decline from 2021.
  • Astellas Pharma average ebitda margin for 2021 was 23.68%, a 2.03% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.